4/27/2015 · Aerie Pharmaceuticals, Inc. ( AERI ) saw a big move last session, as the company's shares fell by nearly 64% on the day. The move came on pretty good. Aerie Pharmaceuticals (AERI) in Focus: Stock Tanks 64% - Tale of the Tape | Nasdaq Our worldwide network of trusted resources allows us to find and deliver the specific parts you need. AERI is an electronic component supplier in America, Asia and Europe. We invite you to learn more about AERI and how we can deliver the quality obsolete electronic parts your business requires. Aerie Pharmaceuticals Stock Price, Chart, Latest News, Technical Indicator and other information Aerie Pharmaceuticals Inc. company facts, information and stock details by MarketWatch. View aeri business summary and other industry information. Check out our AERI stock analysis, current AERI quote, charts, and historical prices for Aerie Pharmaceuticals stock 4/27/2015 · Aerie Pharmaceuticals, Inc. ( AERI ) saw a big move last session, as the company's shares fell by nearly 64% on the day. The move came on pretty good. Aerie Pharmaceuticals (NASDAQ: AERI) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers
Deerfield Management Company oversubscribed 484,643 shares because the company’s stock rose eleven.03% with the market. The hedge fund go by James E. Flynn command 119,000 shares of the medical specialities company at the top of 2017 Q2…
18 Nov 2019 DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. harbor provisions of the Private Securities Litigation Reform Act of 1995. 12 Dec 2019 Stifel Nicolaus reduced their target price on shares of Aerie Pharmaceuticals from $77.00 to $45.00 and set a buy rating on the stock in a 3 Dec 2019 Finally, JMP Securities cut their price objective on shares of Aerie Pharmaceuticals from $58.00 to $52.00 and set a market outperform rating on Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.
AERI, Aerie Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
12/31/2019 · Is Aerie Pharmaceuticals Inc (AERI) A Good Stock To Buy ? A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. Aerie Pharmaceuticals, Inc. (AERI) Q2 2019 Earnings Call Transcript Motley Fool Aug-07-19 06:05PM Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates Zacks Real-time trade and investing ideas on Aerie Pharmaceuticals AERI from the largest community of traders and investors. Get breaking news and analysis on Aerie Pharmaceuticals, Inc. (AERI) stock, price quote and chart, trading and investing tools. Stock quote for Aerie Pharmaceuticals, Inc. Common Stock Common Stock (AERI) with real-time last sale and extended hours stock prices, company news, charts, and 12/27/2019 · AERI: Get the latest Aerie Pharmaceuticals stock price and detailed information including AERI news, historical charts and realtime prices. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.
Apricus Biosciences (APRI) in Focus: Stock Jumps 7% Apricus Biosciences, Inc. ( APRI ) was a big mover last session, as the company saw its shares rise 7% on the day.
Real-time trade and investing ideas on Aerie Pharmaceuticals AERI from the largest community of traders and investors. Get breaking news and analysis on Aerie Pharmaceuticals, Inc. (AERI) stock, price quote and chart, trading and investing tools.
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates Aerie (AERI) delivered earnings and revenue surprises of -2.38% and 5.45%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
8/8/2019 · Zacks Rank & A Key Pick. Aerie currently carries a Zacks Rank #3 (Hold). A better-ranked stock in the healthcare sector is Roche RHHBY, which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Roche’s earnings per share estimates have increased from $2.41 to $2.50 for 2019 in the past 60 AERI Real Time Stock Quote - Get Aerie Pharmaceuticals, Inc. Common Stock (AERI) last sale data in real-time at NASDAQ.com. Aerie Pharmaceuticals, Inc . AERI is scheduled to report first-quarter 2018 results on May 8, after the market closes . Last quarter, the company. 7/31/2019 · Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aerie Pharmaceuticals, Inc. (AERI) : Free Stock Analysis Report To read this article on Zacks.com click here.
Real time Aerie Pharmaceuticals (AERI) stock price quote, stock graph, news & analysis. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise The 10 analysts offering 12-month price forecasts for Aerie Pharmaceuticals Inc The current consensus among 11 polled investment analysts is to Buy stock in Analyzing Aerie Pharmaceuticals (NASDAQ:AERI) stock? View AERI's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC Their average twelve-month price target is $42.82, suggesting that the stock has a possible upside of 77.60%. The high price target for AERI is $56.00 and the Real-time trade and investing ideas on Aerie Pharmaceuticals AERI from the largest community of traders and investors.